Alamar Biosciences
ALMR · NASDAQ
$28.16+$1.86 (+7.07%)TodayMarket closed ·
Prev close $26.30
Who owns ALMR
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 58.7% of ALMR’s shares.
- Qiming Venture Partners15.3%
- Illumina Innovation Funds9.2%
- Sherpa Healthcare Partners7.2%
- Sands Capital Ventures LLC6.1%
- Next 6 largest institutions21.0%
- All other shareholders41.3%
| Holder | Shares | % of shares |
|---|---|---|
| Qiming Venture Partners | 10.59M | 15.29% |
| Illumina Innovation Funds | 6.36M | 9.18% |
| Sherpa Healthcare Partners | 4.97M | 7.17% |
| Sands Capital Ventures LLC | 4.23M | 6.10% |
| Luo (Yuling Ph.D.) | 3.09M | 4.46% |
| Luo (Lian) | 2.98M | 4.30% |
| Samsara BioCapital, LLC | 2.48M | 3.58% |
| Chen (Shiping Ph.D.) | 2.43M | 3.51% |
| T. Rowe Price Investment Management, Inc. | 2.20M | 3.18% |
| ARK Investment Management LLC | 1.37M | 1.98% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| ARK Genomic Revolution ETF | 1.01M | 1.46% |
| ARK Venture Fund | 531.79K | 0.77% |
| AB Small Cap Growth Portfolio | 445.30K | 0.64% |
| T. Rowe Price Small Cap Stock Fund | 355.86K | 0.51% |
| Columbia Small Cap Growth Fund | 345.77K | 0.50% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of ALMR in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Brottem John L. | Award | 85.00K | — |
| Brottem John L. | Award | 29.00K | — |
| RAGUSA ROBERT P | Award | 25.60K | — |
| RAGUSA ROBERT P | Award | 5.69K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 2.81M
- Days to cover
- 4.25
- % of shares outstanding
- 4.06%
- Average daily volume
- 661.42K
- Change since last report
- +32.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.